Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gel-One in Patients with Knee Osteoarthritis (confirmatory study)
jRCT2031240621Phase 3Recruiting
- Sponsor
- Seikagaku Corporation
- Start
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Gel-One arm with Placebo arm (2 arms). Primary endpoint: WOMAC pain subscore change from baseline. Started Feb 2025; status: recruiting.
02
Drugs
sodium hyaluronate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2031240621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240621.